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Abstract 
BACKGROUND: Maternal mortality ratios (MMR) are still unacceptably high in many low-income countries 
especially in sub-Saharan Africa. MMR had been reported to have improved from an initial 3,026 per 100,000 live 
births in 1999 to 941 in 2009, at the University of Calabar Teaching Hospital (UCTH), Calabar, a tertiary health 
facility in Nigeria. Post-partum haemorrhage and hypertensive diseases of pregnancy have been the common 
causes of maternal deaths in the facility.  
AIM: This study was aimed at determining the trend in maternal mortality in the same facility, following institution 
of some facility-based intervention measures. 
METHODOLOGY: A retrospective study design was utilised with extraction and review of medical records of 
pregnancy-related deaths in UCTH, Calabar, from January 2010 to December 2014. The beginning of the review 
period coincided with the period the “Woman Intervention Trial” was set up to reduce maternal mortality in the 
facility. This trial consists of the use of Tranexamic acid for prevention of post-partum haemorrhage, as well as 
more proactive attendance to parturition. 
RESULTS: There were 13,605 live births and sixty-one (61) pregnancy-related deaths in UCTH during the study 
period. This yielded a facility Maternal Mortality Ratio of 448 per 100,000 live births. In the previous 11-year period 
of review, there was sustained the decline in MMR by 72.9% in the initial four years (from 793 in 2010 to 215 in 
2013), with the onset of resurgence to 366 in the last year (2014). Mean age at maternal death was 27 ± 6.5 
years, with most subjects (45, 73.8%) being within 20-34 years age group. Forty-eight (78.7%) were married, 26 
(42.6%) were unemployed, and 33 (55.7%) had at least secondary level of education. Septic abortion (13, 21.3%) 
and hypertensive diseases of pregnancy (10, 16.4%) were the leading causes of death. Over three quarters (47, 
77.0%) had not received care from any health facility. Most deaths (46, 75.5%) occurred between 24 and 97 
hours of admission. 
CONCLUSION: Compared with previous trends, there has been a significant improvement in maternal mortality 
ratio in the study setting. There is also a significant change in the leading cause of maternal deaths, with septic 
abortion and hypertensive disease of pregnancy now replacing post-partum haemorrhage and puerperal sepsis 
that was previously reported. This success may be attributable to the institution of the Woman trial intervention 
which is still ongoing in other parts of the world. There is, however, need to sustain effort at a further reduction in 
MMR towards the attainment of set sustainable development goals (SDGs), through improvement in the provision 
of maternal health services in low-income countries. 
 
 
 
Introduction 
 
Maternal deaths are still unacceptably high in 
many low-income countries, where pregnancy and 
childbirth are high-risk events that constitute major 
public health challenge [1]. Consequently, concerted 
efforts have been made, including long-term goals 
and programs aimed at improving maternal morbidity 
and mortality [2] [3]. One of such goals (the 5
th
 
Millennium Development Goal (MDG-5)), which aimed 
at reducing maternal deaths by three-quarters 
between 1990 and 2015, has been attained by only 
sixteen countries globally [1]. Notwithstanding, there 
has been an improvement in reduction of maternal 
mortality ratios (MMR) globally, with a report indicating 
0.3% reduction in the initial five years and 2.7% 
reduction in the later years of the 15-year MDG span 
[1]. Great achievement in the MDG-5 target is 
particularly notable in the south, east, and Southeast 
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Asian countries, while West and Central African 
regions without exception to Nigeria have made slow 
progress [1]. 
In Nigeria, MMR had initially risen from 704 
per 100,000 live births in 2000, to 800 in 2003 before 
gradual reduction to 545 in 2007, 400 in 2008 to 280 
in 2014 [1] [4]. This recent figure is short of the MDG 
target of 75% reduction in MMR by the end of 2015. 
There is however wide regional variation with higher 
rates in Northern compared with Southern Nigeria [5] 
[6] [7] [8]. Improvement in MMR has also not been 
consistent in many regions, due to intermittent 
financing for implementation of maternal health 
intervention policies and programs as seen in other 
parts of the African continent [9]. Consequently, 
varying intensities of implementation of maternal 
health interventions, have led to varying trends and 
leading causes of maternal deaths in the communities 
[10] [11] [12]. 
A retrospective study of the medical records 
in the University of Calabar Teaching Hospital 
(UCTH), a tertiary hospital in Calabar, Cross River 
State, Nigeria, found a decreasing trend in maternal 
mortality, from 3,026 per 100,000 live births in 1999, 
to 941 in 2009, [6]. During the 11-year study period, 
there were 231 maternal deaths, yielding an average 
maternal mortality ratio of 1,513 per 100,000 live 
births, with most women being 20-34 years old 
(63.3%), married (67.1%) and unemployed (55.4 
(63.3%). Obstetric haemorrhage (33.4%) was the 
commonest cause of death, followed by hypertensive 
diseases of pregnancy (21.2%), septic abortion 
(14.3%) and obstructed labour (9.1%) [6]. 
Archibong et al., in their review of existing 
maternal health policies including an in-depth 
interview with key stakeholders in Cross River state 
health sector, identified factors that may have 
significantly impacted on the state’s maternal 
morbidity and mortality status [13]. Specific programs 
such as Midwife Service Scheme (MSS), National 
Health Insurance Scheme (NHIS) and Integrated 
Maternal Neonatal and Child Health (IMNCH), were 
found to have been adopted and made functional, 
especially through the state’s counterpart funding in 
collaboration with non-governmental partners. Though 
the authors identified that only 40% of budgetary 
allocation to the health sector was usually released, 
they were however unable to obtain adequate 
information on the state’s budgetary income funding 
especially from donor agencies [13]. 
Also, despite poor budgetary allocation and 
release to the health sector, there has been significant 
improvement in water and electricity supply to primary 
healthcare facilities, as well as the construction of 
several road networks by the government of Cross 
River State [13]. These activities with potentially 
significant indirect effect on health outcomes were 
aimed at improving retention and attraction of health 
personnel to rural settings, and reduction in delays of 
providing and receiving essential health services. 
Assessment and evaluation of the impact of these 
infrastructural interventions may be useful towards 
identifying areas of strengths and weaknesses in our 
prevention efforts. 
Therefore, there is still much work to be done 
in containing preventable maternal deaths, especially 
in low-income countries. This position has been 
supported by relevant stakeholders leading to the 
current Sustainable Development Goals (SDG) target 
of having less than 70 maternal deaths per 100,000 
live births by 2030, as a consolidation of the gains of 
the MDG strategic achievements [14] [15]. 
Consequently, it is key to institute and assess 
maternal death prevention programs and practices, to 
identify areas of strength and weakness towards re-
evaluation and promotion of best practices. This 
evaluation is especially important in settings with 
dwindling economies such as Nigeria, where there is 
increasing need to do much more with less money 
amidst other competing needs [16]. 
The University of Calabar Teaching Hospital 
(UCTH) was one of the leading recruitment sites for 
the world Maternal Antifibrinolytic trial (Woman Trial). 
This is a large pragmatic randomised double-blind, 
placebo-controlled trial to quantify the effect of early 
administration of tranexamic acid for postpartum 
haemorrhage on maternal death, Peripartum 
hysterectomy and other outcomes. The multi-centre 
trial is coordinated by the London School of Hygiene 
and Tropical Medicine [17]. The Trial was commenced 
in 2009, and over 16000 women were randomised, 
and the target sample size of 20,000 eligible women 
was attained in August 2016. The first and the second 
nested study aimed to evaluate the effect of 
tranexamic acid on markers of coagulation and 
hemostatic effect of tranexamic acid in randomised 
women respectively. Although the trial has been 
concluded, there is need to evaluate its impact on 
MMR in the region. This study was therefore aimed at 
assessing a 5-year trend in maternal mortality in 
UCTH Calabar, Nigeria, following institution of these 
interventions.  
 
 
Methodology 
 
A retrospective review of clinical data was 
carried out for all maternal deaths that occurred in 
UCTH within the study period of January 2010 when 
the interventions were commenced, to December 
2014, using hospital records. This activity was 
conducted with assistance from three (3) trained 
medical research assistants. Records that were 
mutilated beyond recognition of basic 
sociodemographic data, as well as those that lacked 
information on the cause of maternal death,  were 
excluded. Available records of live births during the 
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study period were also obtained from the medical 
records unit. Ethical approval for the study was 
obtained from UCTH health research ethics 
committee. Maternal death was defined as the death 
of a woman while pregnant or within 42 days of 
termination of pregnancy, irrespective of the duration 
and site of the pregnancy, from any cause related to 
or aggravated by the pregnancy or its management 
but not from accidental or incidental causes [18]. 
Socio-demographic characteristics, as well as the 
number and causes of death, were determined. Place 
of initial care and duration of admission before death 
was also determined. The number of live births during 
the study period was also determined. Data were 
entered and analysed using SPSS version 21.0.  
 
 
Results 
 
Sixty-one (61) maternal deaths occurred in 
UCTH, Calabar, during the study period (2010-2014), 
with an estimated maternal mortality ratio of 448 
maternal deaths per 100,000 live births (Table 1). 
Table 1: Trend in Maternal Mortality Ratio in UCTH (2010-2014) 
Year No. Maternal deaths n 
(%) 
No. Live Births MMR per 100,000 live 
births 
2010 21 (34.4) 2,647 793 
2011 18 (29.5) 3,482 517 
2012 10 (16.4) 3,051 328 
2013 6 (9.8) 2,787 215 
2014 6 (9.8) 1,638 366 
Total 61 (100) 13,605 448 
MMR=Maternal Mortality Ratio 
  
This excludes one subject whose hospital 
record was mutilated beyond recognition of basic 
socio-demographic data and maternal cause of death. 
There was a significant decline in maternal mortality 
ratio from 793 in 2010 to 215 in 2013 and gradual 
resurgence in 2014.  
Table 2: Socio-demographic characteristics of maternal deaths 
(subjects) (N=61) 
Variable Frequency Percent 
Age group   
< 15 1 1.6 
15-19 5 8.2 
20-24 10 16.4 
25-29 22 36.1 
30-34 13 21.3 
35-39 8 13.1 
>40 2 3.3 
Total 61 100 
Marital status   
Married 48 78.7 
Single 10 16.4 
Cohabiting 3 4.9 
Total 61 100 
Occupation   
Civil servant 7 11.5 
Business woman / trader 18 29.5 
Student 5 8.2 
House wife 5 8.2 
Unemployed 26 42.6 
Total 61 100.0 
Educational level   
Primary 25 41.0 
Secondary 31 50.8 
Tertiary 3 4.9 
Not stated 2 3.3 
Total 61 100.0 
Mean age at maternal death was 27.7 ± 6.5 
years, with most deaths (45, 73.8%) occurring within 
20 to 34 years of age. Over three-quarters (78.7%) 
were married, while 25 (41.0%) had an occupation as 
civil servant (7, 11.5%) or businesswoman/trader (18, 
29.5%). Thirty-three (55.7%) had at least secondary 
level of education (Table 2). 
Approximately three-quarters (45, 73.8%) of 
maternal deaths were attributable to direct causes. 
Septic abortion (13, 21.3%) was the commonest 
cause of maternal death, followed by hypertensive 
diseases of pregnancy (10, 16.4%). Relatively less 
common causes were antepartum haemorrhage (5, 
8.2%), prolonged obstructed labour (4, 6.6%) and 
molar pregnancy (4, 6.6%). Malaria in pregnancy (4, 
6.6%), and AIDS (4, 6.6%) were the commonest 
indirect cause of death. Other medical causes of 
maternal deaths included congestive cardiac failure 
(3, 4.9%), pulmonary embolism (2, 3.3%), while 
hematologic causes were aplastic anaemia (1, 1.6%) 
and sickle cell disease (1, 1.6%), (Table 3). 
Table 3: Comparison of causes of maternal death in UCTH 
Cause of Death 1999 – 2009
*
 2010 - 2014 Percentage 
change Frequency Percentage Frequency Percentage 
Direct causes      
Septic abortion 15 6.5 13 21.3 +14.8 
Hypertensive disease of 
pregnancy 49 21.2 10 16.4 -4.8 
Antepartum hemorrhage 11 4.8 5 8.2 +3.4 
Prolonged obstructed 
labor 21 9.1 4 6.6 -2.5 
Molar pregnancy 0 0 4 6.6 +6.6 
Puerperal sepsis 33 14.3 3 4.9 -9.4 
Intrauterine fetal death 
septicemia 0 0 2 3.3 +3.3 
Post-partum hemorrhage 66 28.6 2 3.3 -25.3 
Ectopic pregnancy 6 2.6 1 1.6 -1 
Amniotic fluid embolism 0 0 1 1.6 +1.6 
Indirect causes      
Malaria in pregnancy 12 5.2 4 6.6 +1.4 
Aids 11 4.7 4 6.6 +1.9 
Congestive cardiac 
failure 0 0 3 4.9 +4.9 
Pulmonary embolism 0 0 2 3.3 +3.3 
Anesthetic complication 4 1.7 1 1.6 -0.1 
Aplastic anemia 0 0 1 1.6 +1.6 
Sickle cell disease 0 0 1 1.6 +1.6 
Hepatitis/jaundice in 
pregnancy 3 1.3 0 0 -1.3 
Total 231 100 61 100 - 
*-Obtained from table 4 of the previous study on trend in maternal causes of death (1999-
2009) in same study setting
6
.  
 
The common age groups for the occurrence 
of maternal death due to septic abortion were 15-19 
(4, 30.8%) and 25-29 (5, 38.5%) years). Half of the 
maternal deaths due to hypertensive diseases of 
pregnancy, prolonged obstructed labour and molar 
pregnancy occurred among women who were 25-29 
(5, 50%), 20-24 (2, 50%) and greater than 39 (2, 50%) 
years old respectively. All the four maternal deaths 
due to malaria occurred at 30 years of age (Table 4). 
Most subjects (58, 95.0%) had initially sought 
none (47, 77.0%) or hospital of lower quality (11, 
18.0%) before presenting at the study centre. 
Approximately three-quarters of maternal deaths (46, 
75.5%) occurred within 25 and 96 hours of admission 
(Table 5). 
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Table 4: Age distribution of common causes of maternal 
deaths in UCTH (2010-2014) 
Variable(years) Frequency Per cent Mean age (years) 
Septic Abortion 
  
 
15-19 4 30.8 24.2 ± 6.9 
20-24 2 15.4  
25-29 5 38.5  
35-39 2 15.4  
Total 13 100  
Hypertensive diseases of pregnancy 
 
 
20-24 2 20 27.6 ± 4.8 
25-29 5 50  
30-34 2 20  
35-39 1 10  
Total 10 100  
Prolonged obstructed labour 
  
 
<15 1 25 21.8 ± 6.3 
20-24 2 50  
25-29 1 25  
Total 4 100  
Molar pregnancy 
  
 
25-29 1 25 39.3 ± 8.0 
35-39 1 25  
>40 2 50  
Total 4 100  
Malaria in pregnancy 
  
 
30-34 4 100 30.0 ± 0.0 
 
 
 
Discussion 
 
There has been varying degrees but 
significant reduction in maternal deaths globally, with 
many low-income countries, however lagging behind. 
In this facility-based study, annual maternal mortality 
ratio was found to have decreased quite consistently 
in the last five years. This is in keeping with global 
expectations towards the attainment of the MDG-5 
target [15]. This success could be attributable to 
several on-going intervention programs. Previous 
studies have shown that a significant proportion of 
maternal mortality and life-threatening complications 
occurred in women who did not receive antenatal care 
but referred to the maternity unit in emergency 
condition [6]. In 2010, the Cross River State 
legislators approved the Governor’s request for free 
maternal care services to all categories of pregnant 
women in the State [13].  
Table 5: Pattern of the health-seeking behaviour of subjects 
Variable Frequency Percentage 
Place of initial care   
None 47 77.0 
Hospital of lower status 11 18.0 
Same hospital 3 5.0 
Total 61 100.0 
Duration of admission before death   
<24 hours 8 13.1 
25-48 hours 19 31.2 
49-96 hours 27 44.3 
97 hours - 10 days 6 9.8 
>10 days 1 1.6 
Total 61 100.0 
 
This was to promote the number of antenatal 
clinic attendants and encourage women to utilised 
skilled birth attendants in the state government-owned 
health facilities for labour and deliveries. Increased 
utilisation of skilled birth attendants might have 
contributed to the decline in incidences of obstetric 
complications because, in the last five years, the 
Cross River State government has been offering free 
maternal and newborn care in all the primary and 
secondary health facilities in the state [13]. This has 
increased the number of antenatal attendants; 
hospital supervised deliveries and prompt referral. 
Analysis of health facility-based data by Pathfinder 
International in a stakeholders’ forum has shown a 
gradual decline in maternal mortality and a 
remarkable uptake in obstetrics and neonatal services 
including HIV and contraception programs in the state 
[19]. 
Much of the success of improvement in 
maternal mortality seen in this study might have also 
been influenced by the dedicated implementation of 
the Woman Trial. In this trial, every woman with 
postpartum haemorrhage was given 1 to 2 gm of 
tranexamic acid or placebo. During the five year 
period more than 500 women with PPH were recruited 
in which perhaps, more than have of them might have 
been treated. This is reflected in the significant 
difference in the proportion of maternal deaths caused 
by postpartum haemorrhage (PPH) comparing pre-
intervention and intervention periods [6]. In this study, 
a significant reduction in the occurrence of PPH was 
the main cause of the significant reduction in maternal 
deaths [20]. In a recent Cochrane review [21] that 
included 12 trials involving 3285 women undergoing 
caesarean section (9 trials, 2453 participants) and 
spontaneous labour (3trials, 832 participants), 
Tranexamic acid (TXA), in addition to other 
uterotonics, decreased postpartum blood loss and 
prevented PPH and blood transfusion. 
Furthermore, in a double-blinded trial by Xu J 
and colleagues [22], TXA was shown to significantly 
reduce obstetric haemorrhage during caesarean 
section compared to the control group      (P < 0.01). 
Also, the quantity of total blood loss from placental 
delivery to 2 hours postpartum was significantly 
reduced (P = 0.02) in TXA group than the control. 
Woman trial which recruited 20,000 women with PPH 
was concluded in March 2016, and the data were 
analysed in September 2016 and has been published 
in Lancet in December 2016. The results showed a 
significant reduction in primary outcomes- maternal 
mortality and peripartum hysterectomy in the treated 
group compared with the placebo group. 
Also, through the Cross River State essential 
drugs program, iron and folic acid supplements are 
readily available in most primary and secondary 
health facilities which are dispensed free to pregnant 
women. This may have contributed to the low 
prevalence of anaemia in pregnancy. It is estimated 
that anaemia may be the underlying factor-
responsible for as much as 20% of all maternal deaths 
in sub- Sahara Africa [23]. The most suitable mass 
intervention to prevent anaemia in pregnancy is the 
administration of haematinics to pregnant women 
aimed at raising the haemoglobin concentration. 
Furthermore, availability of highly subsidised 
contraceptive services may be responsible for the 
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decreased incidence of death from unsafe abortion 
due to a possible reduction in some unwanted 
pregnancies [24]. 
Worthy of note is the effort of various NGOs in 
improving maternal and newborn care during the 
study period. For instance, Tulsi-Chanrai foundation, 
an Indian NGO in partnership with the state ministry of 
health since 2009, has trained different categories of 
health workers in the state on the use of partograph, 
infection prevention, management of preeclampsia/ 
eclampsia and active management of the third stage 
of labour [25]. Protocols and guidelines for treatment 
of obstetric complications are now conspicuously 
displayed in the form of wall-chart in the maternity 
units of hospitals and health centres. Sustained 
training on Focused Antenatal Care has been 
conducted across the three major districts courtesy of 
Malaria Action Program for States (MAPS) in 
conjunction with USAID and Global Fund. Among 
other benefits, this emphasises on complication 
readiness, recognition of danger signs, birth 
preparedness and family-centred care during 
pregnancy [26]. Previous studies have shown that 
when maternal and newborn care services are offered 
free highly subsidised, there is a positive impact on 
health demography of the population [27].  
In this study, septic abortion is now a leading 
cause of maternal death, replacing post-partum 
haemorrhage which was reported in the previous 
study in the same setting. In the data presented by 
Pathfinder International [19], ‘stock out’ of parenteral 
antibiotics was commonly reported in the monthly 
summary form compared to other essential drugs like 
misoprostol. Significant reduction in the occurrence of 
PPH as the cause of maternal death may be due to 
increased utilisation of misoprostol for management 
and prevention of PPH during the study period [28]. 
This is in keeping with similar reports in Bangladesh 
which reported significantly lower mortality ratios in 
higher compared with lower and no misoprostol 
coverage areas (38 vs 45 vs 51) maternal deaths per 
100,000 live births, respectively [29]. These findings 
were reported despite similar and inadequate 
utilisation of skilled birth attendants in the study areas 
[29]. 
Malaria in pregnancy constituting 6.6% was 
the commonest indirect cause of death in this study. 
This proportion is slightly higher than what was 
reported in the previous study in the same setting by 
Agan et al. (6.6% vs 5.2%), suggesting the need for 
improvement in the implementation of malaria 
prevention measures [6]. Difficulty in the improvement 
of malaria in pregnancy prevention in the study setting 
could be due to the high prevalence of undetected 
asymptomatic malaria parasitaemia reported in 
previous studies, with potential progression to more 
severe and even fatal disease [30] [31]. This study is 
however limited by the inability to assess maternal 
deaths that may have occurred in transit to health 
facilities, as well as the effect of sociopolitical and 
other factors that may have contributed to the 
improvement in maternal mortality during the study 
period.  
In conclusion, there is a significant decline in 
maternal mortality in the study centre in the last 5 
years. This might be explained by the institution of the 
Woman trial intervention which reduced the 
occurrence and severity of PPH, as well as more 
proactivity of caregivers in their attendance to 
parturition. Given a high proportion of deliveries 
usually occurring in rural settings, there is need to 
consider shortly, institution of the Woman trial in rural 
settings. Such scale-up using the existing primary 
health care facilities may yield accelerated attainment 
of the SDGs, especially in resource-poor settings. 
Septic abortion and hypertensive diseases of 
pregnancy have replaced post-partum haemorrhage, 
which was previously noted as leading cause of 
maternal death. This indicates the need for 
implementation of community and facility-based 
strategies for infection control towards containment of 
septic abortion which is the new leading cause of 
maternal death.  
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